stockrow
Friday 6 November 2026
Export ITGR’s income statement to Excel — free account
Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
126.56
0.19
−0.15%
Follow ITGR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 7 | 5 | 6 |
| 6.11% | 8.58% | 7.50% | 5.97% | ||
| 3.17% | 4.23% | 3.78% | 3.05% | ||
ROIC |
4.70% | 4.25% | 3.74% | 3.16% | |
Return on Tangible Assets |
9.57% | 12.87% | 11.40% | 9.13% | |
Average Days of Receivables |
68.15 | 64.47 | 67.07 | 69.00 | |
Free Cash Flow per Share |
3.03 | 2.91 | 3.29 | 2.40 | |
Free Cash Flow |
105.12 | 99.85 | 111.98 | 81.82 | |
Capital Expenditures |
(91.03) | (89.72) | (93.46) | (94.66) | |
| Other line items | |||||
Cash ROIC |
3.53% | 3.32% | 3.70% | 2.72% | |
Accounts Receivable Turnover |
6.27 | 6.15 | 5.75 | 5.57 | |
Accounts Payable Turnover |
12.61 | 12.04 | 11.95 | 12.42 | |
Inventory Turnover |
5.40 | 5.02 | 4.94 | 5.08 | |
Average Days of Payables |
30.51 | 30.73 | 29.80 | 29.43 | |
Days of Inventory on Hand |
68.44 | 76.00 | 76.75 | 73.87 | |
Tax Rate |
(0.18) | (0.11) | (0.06) | (0.04) | |
Research and Development Expense of Revenue |
2.67% | 2.78% | 2.64% | 2.80% | |
Selling, General and Administrative Expense of Revenue |
11.42% | 11.82% | 12.16% | 12.48% | |
Share Based Compensation of Revenue |
1.25% | 1.24% | 1.23% | 1.26% | |
Interest Coverage |
5.12 | 5.34 | 4.64 | 3.87 | |
Operating CF/Net income |
1.91 | 1.34 | 1.60 | 1.70 | |
Depreciation/Fixed assets |
0.26 | 0.27 | 0.27 | 0.27 | |
Capex/Depreciation |
(0.66) | (0.63) | (0.65) | (0.65) | |
Revenue per Share |
53.37 | 54.14 | 54.20 | 53.65 | |
Operating CF per Share |
5.65 | 5.53 | 6.04 | 5.19 | |
Capex per Share |
(2.62) | (2.62) | (2.75) | (2.78) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 |
Columns are period end dates · fundamentals updated 2 Nov 2026